Anocca
PrivateLast Round
Early Funding
Aug 18, 2025
Total Funding Raised
$82.65M
Company Overview
Anocca is a clinical-stage biopharmaceutical company that develops T-cell receptor-engineered T cell (TCR-T) therapies to treat solid tumours and other diseases. Founded in 2014, the company has a fully integrated platform that includes research and development, a custom software ecosystem (AnoccaOS), and in-house cGMP manufacturing facilities in Södertälje, Sweden. Anocca's proprietary technology aims to scale the development of TCR-T cell therapies, enabling the systematic creation of personalized treatments for broad patient populations. The company is advancing its pipeline, with its lead program, VIDAR-1, in early-stage clinical trials for pancreatic cancer. Anocca is privately held and has received significant venture capital funding from investors including Mellby Gård, AMF, and Ramsbury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anocca Comps
Public and private peers based on sector, stage, and business model.
Anocca Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 18, 2025 | ||||
| Growth Equity | May 31, 2023 |
Key People
Founding team and executive leadership
Anocca Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AMF Tjänstepension | Growth Equity |
| Mellby Gård | Early Funding, Growth Equity |
| Ramsbury Invest | Growth Equity |
| Swedbank Robur | Growth Equity |
| Michano | Growth Equity |
| Nidoco | Growth Equity |
Anocca Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anocca's valuation, stock price, and market status.
